Conditions tested were T cell activation and inhibition by 3-MB-PP1. With 3-MB-PP1 Figure S6 . Intracellular calcium levels of ZASE-expressing cells upon simultaneous addition of anti-TCR antibody and inhibitor. Cells were treated with 4OHT, followed by the concurrent addition of anti-TCR antibody and 3-MB-PP1, and calcium levels were monitored over time. Figure S7 . OFF-ON activity of ZAP70 switch. Cells were incubated with 4OHT and 3-MB-PP1, followed by a washout of 3-MB-PP1. They were then left for various time points (0hr, 2hr, 4hr, 8hr, 16hr) before activation. CD69 levels were measured by flow cytometry (mean ± s.d., n = 3). Control samples include cells that were not incubated with 3-MB-PP1 but were activated (no inhibition, positive control), and cells that were inhibited with 3-MB-PP1 but were not activated (no activation, negative control). Variant ZASE2 in ZAP70(-) mutant ZAP70(-) mutant Figure S7 . OFF-ON activity of ZAP70 switch. Cells were incubated with 4OHT and 3-MB-PP1, followed by a washout of 3-MB-PP1. They were then left for various time points (0hr, 2hr, 4hr, 8hr, 16hr) before activation. CD69 levels were measured by flow cytometry (mean ± s.d., n = 3). Control samples include cells that were not incubated with 3-MB-PP1 but were activated (no inhibition, positive control), and cells that were inhibited with 3-MB-PP1 but were not activated (no activation, negative control). Figure S9. ZAP70 switch activity in Jurkat cells expressing a Her2 CAR. A) P116 cells expressing the ERT2-ZAP70 fusion protein and a CAR were stimulated with 4OHT and Her2 antigen, and CD69 levels measured. B) ZASE and CAR-expressing P116 cells were treated with combinations of 4OHT, Her2, and 3-MB-PP1 to observe whether ZASE is compatible with CARs. CD69 levels were measured as an indicator of T cell activity. ERT2 ZAP70 mCherry ERT2 ZAP70AS mCherry
